More Exclusive Features

To address lack of regulatory standards, NGOs test CBD products in Europe

The CBD market in Europe faces a challenge that would look familiar to many U.S. producers: Its popularity is on the rise, despite lack of clear rules and industrywide standards. For consumers, this means legitimate products can often be found right next to others with significantly less CBD than advertised or with potentially harmful contaminants. This is especially […]

Read More

Canada to consult public, businesses on natural health products containing hemp

Canada’s top health agency plans to launch public consultations on a proposed approach for regulating natural health products containing cannabis, Hemp Industry Daily has learned. Any subsequent regulations by Health Canada could have major implications for Canada’s CBD industry, which currently can be accessed only with a doctor’s prescription or through marijuana retailers. “Health Canada […]

Read More

Five things CBD insiders are looking for from the FDA

The hemp industry cheered when the plant was legalized last year. But the promise of hassle-free commerce from hemp’s most valuable product – the cannabinoids in its flowers – has remained elusive. That’s because the U.S. Food and Drug Administration waited less than 24 hours after hemp was legalized to extinguish hopes that cannabinoids, especially […]

Read More

‘Distinct products, distinct plants – that’s the only way’: Part 2 of a Q&A with CV Sciences exec Doug Mackay

As the hemp industry anticipates the U.S. Food and Drug Administration’s (FDA) first public hearing to start the process of regulating hemp extracts such as CBD in food, beverages and cosmetics, among others, a former dietary supplement executive now working with San Diego-based CBD manufacturer CV Sciences offers insight on regulatory compliance. In Part 1 […]

Read More

Multistate producer Hemptown ready to scale hemp production, processing sites with $23 million capital raise

Hemptown USA, a multistate hemp producer and CBD company, completed a $23 million round of financing last week, allowing it to move forward with ambitious expansion plans in Colorado, Kentucky, Northern California and Oregon. The company will use the raise to purchase $5.5 million worth of Oregon CBD seeds. The rest will be used to: […]

Read More

‘Be at the table, or you’re on the plate’: Part 1 of a Q&A with CV Sciences exec Doug Mackay

For a CBD company looking to see its products sold alongside traditional supplements and functional foods, what better place to look than a longtime executive from the natural-products world? In late March, San Diego-based CBD manufacturer CV Sciences brought on Douglas Mackay, a naturopathic doctor and former senior vice president with the Council for Responsible […]

Read More